Myriad Genetics (MYGN) Announces Positive Results for myChoice HRD Test in TESARO (TSRO) Collaboration
Tweet Send to a Friend
Myriad Genetics, Inc. (Nasdaq: MYGN) announced that its myChoice HRD test successfully identified an increased number of patients with ovarian ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
